BIAFW
bioAffinity Technologies, Inc.
NASDAQ · Healthcare · Medical - Diagnostics & Research · US
$0.30
+30.13%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 0.08x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 0.08x
- Price / sales
- 0.05x
- Price / cash flow
- -0.03x
Enterprise value
- Enterprise value
- -$674.6K
- EV / sales
- -0.11x
- EV / EBITDA
- 0.05x
- EV / EBIT
- 0.05x
- Market cap
- $320.1K
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026